BETAXOLOL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Betaxolol Hydrochloride patents expire, and what generic alternatives are available?
Betaxolol Hydrochloride is a drug marketed by Acella, Akorn, Apotex Inc, Medimetriks Pharms, Epic Pharma, and Kvk Tech. and is included in six NDAs.
The generic ingredient in BETAXOLOL HYDROCHLORIDE is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Betaxolol Hydrochloride
A generic version of BETAXOLOL HYDROCHLORIDE was approved as betaxolol hydrochloride by EPIC PHARMA on October 22nd, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BETAXOLOL HYDROCHLORIDE?
- What are the global sales for BETAXOLOL HYDROCHLORIDE?
- What is Average Wholesale Price for BETAXOLOL HYDROCHLORIDE?
Summary for BETAXOLOL HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Clinical Trials: | 5 |
Patent Applications: | 1,685 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in BETAXOLOL HYDROCHLORIDE? | BETAXOLOL HYDROCHLORIDE excipients list |
DailyMed Link: | BETAXOLOL HYDROCHLORIDE at DailyMed |
![BETAXOLOL HYDROCHLORIDE drug patent expirations Drug patent expirations by year for BETAXOLOL HYDROCHLORIDE](/p/graph/s/t/BETAXOLOL_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for BETAXOLOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Zagazig University | Phase 2 |
National Institute on Aging (NIA) | Phase 4 |
The New York Community Trust | Phase 4 |
Pharmacology for BETAXOLOL HYDROCHLORIDE
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |